The Bear Moon study, which is evaluating the Bear ACL implant against autograft bone-patellar tendon-bone ACL reconstruction, completed enrollment, according to a July 7 news release.
The study, sponsored by the National Institutes of Health, will span six clinical centers and include 150 patients. Cleveland Clinic is leading the research. The Bear implant is designed to help repair the ACL using a patient’s own blood.
“The current standard of care for ACL reconstruction involves using a graft from the patient’s hamstring or patellar tendon to replace the ACL,” Kurt Spindler, MD, the study’s principal investigator said in the release. “Previous BEAR Implant studies compared the BEAR Implant to the hamstring autograft. BEAR MOON will add important clinical insights on the effectiveness of the BEAR Implant compared to BPTB, which is one of the most widely used grafts in ACL reconstruction.”
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
